EligibleTrials

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Recruiting · NCT06596746 · Observational (researchers observe without assigning treatment) · Lead sponsor: Casa di Cura San Raffaele Cassino

View the official record on ClinicalTrials.gov →
Multiple sclerosisAlzheimer's disease

Interventions studied

Observation

What this trial is about

MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.

Who can take part

Age range
10 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.